Candesartan cilexetil
SIGMA/SML0245 - ≥98% (HPLC)
Synonym: 2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid 1-
CAS Number: 145040-37-5
Empirical Formula (Hill Notation): C33H34N6O6
Molecular Weight: 610.66
MDL Number: MFCD00871371
Linear Formula: C33H34N6O6
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C33H34N6O6/c1-3-42-32- |
| InChI key | GHOSNRCGJFBJIB-UHFFFAOYSA |
| originator | Takeda |
| Quality Level | 100 ![]() |
| SMILES string | CCOc1nc2cccc(C(=O)OC(C)OC |
| solubility | DMSO: ≥15 mg/mL |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Candesartan cilexetil is a non-peptide angiotensin (AT2) receptor antagonist. |
| Biochem/physiol Actions: | Candesartan cilexetil is the prodrug form of the potent angiotensin II receptor antagonist, candesartan. The prodrug is cleaved by esterases within the intestine to liberate the active molecule. |
| Features and Benefits: | This compound is featured on the Angiotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Takeda . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10 mg in glass bottle |
| Packaging: | 50 mg in poly bottle |
| Symbol | ![]() GHS08,GHS09 |
| Signal word | Warning |
| Hazard statements | H361 - H400 |
| Precautionary statements | P201 - P273 - P308 + P313 |
| Hazard Codes | T,N |
| Risk Statements | 61-48/20-50 |
| Safety Statements | 53-45-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



